Board of Directors

  • Jan van Koeveringe, PhD

    Jan van Koeveringe, PhD

    Chairman of the Board


    Dr. van Koeveringe received his PhD in organic chemistry from the University of Leiden (The Netherlands). He was a member of the Pharma Executive Committee of Roche, leading global technical operations from 2000 to 2010. Dr. van Koeveringe remains actively involved in the Pharmaceutical Industry. With his longstanding experience, he will strongly support Senn’s successful future development.

  • Hans-Peter Wyss, lic. oec. publ., dipl. Wirtschaftsprüfer

    Hans-Peter Wyss, lic. oec. publ., dipl. Wirtschaftsprüfer

    Member of the Board

    Hans-Peter Wyss holds a bachelor in finance and graduated in economics at the University of Zurich. He held various positions in the areas of audit, risk management, corporate finance and advisory in big-4 audit and consulting firms in Switzerland. Since he became a partner of Deloitte in 2005 he advised a large number of global, international and local companies as well as entrepreneurs. Hans-Peter Wyss retired from his position in 2013 and started his own advisory firm.

  • Matthias Senn

    Matthias Senn

    Member of the Board

    Matthias Senn completed his professional training at Givaudan (Hoffmann La Roche) in Dübendorf, near Zürich. In 1981 he became responsible for Senn Chemicals new R & D laboratory. During the following years he helped to adapt the organizational structure to complement the demands of the steadily growing company. In 1993 further studies at the University of Zürich.

  • Jürg Peyer, PhD. iur.

    Jürg Peyer, PhD. iur.

    Member of the Board


    Jürg Peyer is practicing attorney since 1974, after he finished his studies at the Universities of Geneva and Zurich. He is a creative tactician, who can also keep a cool head even in seemingly hopeless situations and resolve tensions with humor.